The benzohydrazide mol-ecule of the title compound, C(14)H(10)BrClN(2)O(5)·CH(3)OH, is non-planar, the two aromatic rings at either side of the -C(=O)-NH-N=CH- unit being twisted by 5.9 (1)°. The benzohydrazide mol-ecule is linked to the solvent mol-ecule by an O-H⋯O hydrogen bond. Mol-ecules are connected by further O-H⋯O hydrogen bonds and an N-H⋯O link into a two-dimensional array.
There are two mol-ecules in the asymmetric unit of the title compound, C(14)H(10)N(2)O: the dihedral angles between their aromatic ring planes are 47.4 (4) and 46.8 (3)°. In the crystal structure, mol-ecules are linked by N-H⋯N hydrogen bonds from the secondary nitro-gen N-H donor to the tertiary N-atom acceptor of a symmetry-related neighbour, resulting in hydrogen-bonded chains. The two independent chains both propagate in [100].
A cytotoxic bisindole alkaloid possessing an unprecedented structure in which two indole moieties are bridged by an aromatic spacer unit has been isolated from Alstonia angustifolia. The structure was established by analysis of the spectroscopic data and confirmed by X-ray diffraction analysis. A possible biogenetic pathway from pyrocatechuic acid and pleiocarpamine is presented.
3-Oxoolean-1-en-28-oic acid, isolated from the bark of Walsura pinnata Hassk, crystallized from n-hexane as an n-hexane 0.25-solvent 0.25-hydrate, C(30)H(46)O(3)·0.25C(6)H(14)·0.25H(2)O. There are two independent mol-ecules in the asymmetric unit of the title compound. The three six-membered cyclo-hexane rings in each mol-ecule adopt chair conformations and the carboxyl substituent occupies an axial/equatorial position. The two independent mol-ecules are linked by a pair of O-H(carbox-yl)⋯O hydrogen bonds into a dimer. The n-hexane mol-ecule is disordered about a twofold rotation axis and the water mol-ecule lies on a twofold rotation axis. In addition, the cyclo-hexone carbonyl group of one of the independent mol-ecules is disordered over two sites with occupancies of 0.75 and 0.25.
In the crystal structure of 2-bromo-beclometasone dipropionate [systematic name: (8S,9R,10S,11S,13S,14S,16S,17R)-2-bromo-9α-chloro-11-hydr-oxy-10,13,16-trimethyl-3-oxo-17-[2-(propion-yloxy)acet-yl]-6,7,8,9,10,11,12,13,14,15,16,17-dodeca-hydro-3H-cyclo-penta-[a]phenanthren-17-yl propionate], C(28)H(36)BrClO(7), the six-membered ring with the 1,4-diene-3-one composition is planar (r.m.s. deviations = 0.03 and 0.04 Å for the two independent mol-ecules), whereas the remaining six-membered rings have chair conformations. Each of the independent mol-ecules self-associates via O-H⋯O(propionate) hydrogen bonding, generating a supra-molecular chain running along the b axis. The crystal is twinned, with the monoclinic unit cell emulating an orthorhomic crystal system; the major twin component constitutes approximately 60%.
In the crystal structure of (8S,9R,10S,11S,13S,14S,16S,17R)-9α-bromo-11-hydr-oxy-10,13,16-trimethyl-3-oxo-17-[2-(propion-yloxy)acet-yl]-6,7,8,9,10,11,12,13,14,15,16,17-dodeca-hydro-3H-cyclo-penta-[a]phenanthren-17-yl propionate monohydrate, C(28)H(37)BrO(7)·H(2)O, which has a 9α-Br atom in place of the 9α-Cl atom of monohydrated beclometasone dipropionate, one six-membered ring is planar (r.m.s. deviation = 0.02 Å) owing to its 1,4-diene-3-one composition, whereas the two other six-membered rings each have a chair conformation. The organic mol-ecule and water mol-ecules engage in hydrogen-bonding inter-actions, generating a helical chain running along the c axis of the ortho-rhom-bic unit cell.
The Cu(II) atom in the title compound, [Cu(C(13)H(16)ClN(2)O(2))Cl], exists in a distorted square-planar coordination environment as the deprotonated Schiff base chelates to the Cu(II) atom through three atom sites. In the crystal structure, adjacent mol-ecules are linked by a Cu⋯Cl [3.011 (1) Å] bridge, generating a linear chain running along the b axis of the ortho-rhom-bic unit cell.
The Sn(IV) atom in the title compound, [Sn(C(4)H(9))(2)(C(19)H(13)BrN(2)O(3))], shows a distorted cis-C(2)NO(2)Sn trigonal-bipyramidal coordination. Both butyl chains and the naphth-yl-oxy portion are disordered over two sets of sites of equal occupancy.
The Sn(IV) atom in the title compound, [Sn(C(4)H(9))(2)(C(18)H(11)BrN(2)O(3))], shows a distorted cis-C(2)NO(2)Sn trigonal-bipyramidal coordination. One of the butyl chains is disordered over two sites in a 0.60 (1):0.40 (1) ratio.
In the title compound, C(14)H(10)N(2)O, the organic rings are inclined at an angle of 86.1 (1)°. The angle at the ether O atom is widened to 117.18 (14)°.
The title compound, C(28)H(34)Cl(2)O(7), is a derivative of the glucocorticoid steroid beclomethasone dipropionate. It features an expoxide linkage [angle at oxygen = 96.6 (2)°]. The dichlorocyclohexenone ring adopts an envelope conformation, with the C atom bearing the two Cl substituents representing the flap. The dichloro-methyl C atom deviates by 0.471 (4) Å from the plane defined by the other five atoms, whose maximum r.m.s. deviation is 0.04 Å.
The title compound, C(25)H(34)N(2)O(3)S, is a derivative of N'-benzyl-ideneacetohydrazide having substituents on the acetyl and benzylidenyl parts, and displays a planar C(carbon-yl)-NH-NC(anis-yl) fragment [torsion angle = 174.9 (3)°]. The -NH- unit forms an N-H⋯O hydrogen bond with the carbonyl O atom of an inversion-related mol-ecule.
The Sn(IV) atom in the title compound, [Sn(C(6)H(5))(2)(C(18)H(11)ClN(2)O(3))], is O,N,O'-chelated by the deprotonated Schiff base ligand and further bonded by two phenyl rings in a distorted cis-C(2)SnNO(2) trigonal-bipyramidal geometry [C-Sn-C = 125.7 (2)°]. The two phenyl rings are oriented at a dihedral angle of 55.2 (3)°. Intra-molecular O-H⋯N hydrogen bonding is present in the crystal structure.
In the title compound, C(18)H(21)IO, the cyclo-hexane ring adopts a chair conformation, whereas the cyclo-pentane ring and the ten-membered tetra-line portions each adopt an envelope conformation. For the five-membered ring, the methine C atom deviates by 0.638 (4) Å (r.m.s. of the four other atoms is 0.005 Å) and for the ten-membered ring, the methine C atom constituting the flap deviates by 0.671 (3) Å (r.m.s. of the other nine atoms is 0.066 Å).
In the title compound, C(11)H(9)ClN, the dihedral angle between the aromatic ring planes is 44.2 (1)° and the bridging C-N-C bond angle is 127.60 (19)°. The amino N-H grouping makes a hydrogen bond to the pyridyl N atom of an adjacent mol-ecule across a center of inversion, generating a hydrogen-bonded dimer.
In the mol-ecule of pinnatane A, C(30)H(48)O(3), isolated from the bark of Walsura pinnata Hassk, the four cyclo-hexane rings adopt chair conformations; the carboxyl and hydr-oxy substituents occupy axial positions. The cyclo-hexene ring is envelope-shaped. Adjacent mol-ecules are linked by O-H⋯O hydrogen bonds into a chain running along the c axis.
The central Cd(II) atom in the trinuclear title compound, [Cd(3)(C(14)H(19)N(2)O(3))(2)(CH(3)COO)(4)], lies on a center of inversion and is bonded to the O atoms of four acetate groups as well as to the phenolate O atoms of the mono-deprotonated Schiff base ligands in a distorted all-trans octa-hedral geometry. Two of the acetate groups function in a μ(2)-bridging mode, while the other two each chelate to the terminal Cd(II) atom and simultaneously bind to the central metal atom in a κ(3)-bonding mode. The Schiff base anions N,O-chelate to the terminal metal atoms. The morpholine ring assumes a chair conformation.